Ameritas Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-17,513
Closed -$2.89M 3114
2021
Q2
$2.89M Sell
17,513
-216
-1% -$36.1K 0.1% 195
2021
Q1
$2.72M Hold
17,729
0.1% 206
2020
Q4
$2.22M Sell
17,729
-379
-2% -$42.4K 0.1% 238
2020
Q3
$1.84M Sell
18,108
-298
-2% -$30.4K 0.08% 252
2020
Q2
$1.79M Buy
18,406
+657
+4% +$61.1K 0.09% 238
2020
Q1
$1.47M Hold
17,749
0.08% 250
2019
Q4
$1.97M Hold
17,749
0.09% 252
2019
Q3
$1.76M Buy
17,749
+489
+3% +$48.6K 0.08% 276
2019
Q2
$1.71M Hold
17,260
0.08% 285
2019
Q1
$1.9M Buy
17,260
+160
+0.9% +$16.7K 0.09% 254
2018
Q4
$1.57M Hold
17,100
0.09% 272
2018
Q3
$1.88M Buy
17,100
+2,200
+15% +$229K 0.09% 269
2018
Q2
$1.39M Buy
14,900
+10,696
+254% +$921K 0.07% 380
2018
Q1
$349K Hold
4,204
0.02% 837
2017
Q4
$383K Hold
4,204
0.02% 803
2017
Q3
$325K Buy
4,204
+800
+24% +$60.5K 0.02% 863
2017
Q2
$255K Buy
3,404
+1,315
+63% +$91.2K 0.01% 929
2017
Q1
$136K Buy
+2,089
New +$123K 0.01% 1256

Other funds holding PRAH

Ameritas Investment Partners's PRAH Position: Q3 2021 in Review

Ameritas Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 17,513 shares — an estimated $2.89M sold.

Ameritas Investment Partners first reported a position in PRAH in Q1 2017 and held it in 18 quarters. The position peaked at $2.89M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Ameritas Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 17,513 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.89M.
  • Ameritas Investment Partners first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 18 quarters.
  • Ameritas Investment Partners's PRA Health Sciences, Inc. position peaked at $2.89M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Ameritas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.